SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-16-688849
Filing Date
2016-08-23
Accepted
2016-08-23 17:08:26
Documents
4
Effectiveness Date
2016-08-23

Document Format Files

Seq Description Document Type Size
1 S-8 d245796ds8.htm S-8 38517
2 EX-5.1 d245796dex51.htm EX-5.1 7470
3 EX-23.1 d245796dex231.htm EX-23.1 1684
4 GRAPHIC g245796img.jpg GRAPHIC 7378
  Complete submission text file 0001193125-16-688849.txt   58761
Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Filer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-213267 | Film No.: 161847770
SIC: 2834 Pharmaceutical Preparations